Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity - ScienceDirect
AN OVERVIEW ON CLINICAL TRIALS
Understanding Clinical Trial Terminology: What's a Phase 1, 2 or 3 Clinical Trial? - Concert Pharmaceuticals
Phases of clinical trials | NCIRS
Final Analysis of Results from the Phase Ib/II Trial of Romidepsin and CHOP in Previously Untreated PTCL | Research To Practice
Phase 0/microdosing approaches: time for mainstream application in drug development? | Nature Reviews Drug Discovery
Vaccines | Free Full-Text | Current Clinical Trials Protocols and the Global Effort for Immunization against SARS-CoV-2 | HTML
Colorado COVID Vaccine Guide: How To Find Info Relevant To You | Colorado Public Radio
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2020 - IOS Press
Phases of Cancer Clinical Trials - NCI
Moving Beyond 3+3: The Future of Clinical Trial Design | American Society of Clinical Oncology Educational Book
Clinical Trial Designs & Clinical Trial Phases | Credevo Articles
Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial - The Lancet Oncology
Attachment
Safety and Reactogenicity of an MSP-1 Malaria Vaccine Candidate: A Randomized Phase Ib Dose-Escalation Trial in Kenyan Children | PLOS Clinical Trials
On Biostatistics and Clinical Trials: Phase I Dose Escalation Study Design: "3 + 3 Design"
Phases In Clinical Trials Explained by CRO Diagram Research
Galectin Therapeutics, Inc. Announces Positive Preliminary Results from Phase 1b Clinical Trial of GR-MD-02 and KEYTRUDA® in Advanced Melanoma and Expansion of the Trial | Galectin Therapeutics Inc.
Regulatory Toxicology Presentation Overview - ppt download
Phase 1 Trial of a Therapeutic Anti–Yellow Fever Virus Human Antibody | NEJM
Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies - Annals of Oncology
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial - The Lancet Oncology
Phase I trials as valid therapeutic options for patients with cancer | Nature Reviews Clinical Oncology
